Shares of global pharma stocks slumped on Monday after President Trump vowed to cut drug prices for Americans by as much as 80%.

In a post on his Truth Social platform on Sunday, Trump said the order, to be signed at 9 a.m. Monday, will institute a "most favored nation" policy where the U.S. will pay the same price for ...

IST, the barometer index, the S&P BSE Sensex, zoomed 2,590.57 points or 3.26% to 82,045.04. The Nifty 50 index soared 810.40 points or 3.38% to 24,818.40.

In a post on Sunday evening on Truth Social, President Donald Trump said he would sign an executive order that he says will ...

Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

Cumberland Pharmaceuticals, Inc. ( NASDAQ: CPIX) Q1 2025 Earnings Conference Call May 6, 2024 4:30 PM ET Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - CEO Todd Anthony - VP, ...

Just months in the making, the city’s new facility includes an advanced public safety hub with real-time video analytics and ...

The number of Americans using illicit opioids, including fentanyl, is 20 times higher than previously estimated, according to ...

Corvus Pharmaceuticals shares jumped 29% in premarket trading after new interim data in a study evaluating soquelitinib. Shares were trading around $4.33. The stock is down 38% on the year.

Increased Scrutiny: Means and Kennedy have called for greater transparency in clinical trial data and vaccine safety ...

The phase 2b trial compared four doses of temtokibart to placebo in 262 adults with moderate to severe atopic dermatitis, the ...